In the co-treatment of glioblastoma cells with human astrocytes using TMZ and Bay 11-7082 (a NF-κB inhibitor), the expression levels of GFAP, waveform protein, Notch1, and survivin were significantly reduced. This evidence concerns the gene NFKB1 and glioblastoma.